KORU is a leveraged ETF that seeks 300% of the daily return of the MSCI Korea 25/50 Index, a benchmark of large- and mid-cap South Korean equities. The fund climbed roughly 72% over the last 30 days, rebounding from a closing price near $12.08 to approximately $20.77.

MSTU climbed roughly 70% over the past 30 days, tracking a sharp rebound in Strategy Inc. ( MSTR ) as Bitcoin recovered above $80,000. The fund targets 200% of MSTR's daily return through total return swaps, magnifying both gains and losses.

The Tradr 2X Long BE Daily ETF (BEX) seeks daily investment results equal to 200% of the daily performance of Bloom Energy (BE) , a fuel-cell and clean-power company. BEX rose approximately +51% over the last 30 days, recovering from a closing low near $15.00 to roughly $22.62.

The Tradr 2X Long SMR Daily ETF (SMU) seeks to deliver two times (2x) the daily performance of NuScale Power (SMR) common shares, making it a non-diversified, single-stock leveraged fund. SMU rebounded roughly +37% over the last 30 days, recovering off a July low after a severe drawdown earlier in the period.

IONX is a leveraged exchange-traded fund (ETF) that seeks daily returns equal to two times (200%) the daily price change of IonQ, Inc., a trapped-ion quantum computing company. The fund is actively managed and non-diversified, building its exposure primarily through total-return swaps and U.S. Treasury bill collateral rather than a basket of common stocks.

IRE fell -24.57% to about $7.40 during regular trading, versus a prior close of $9.81. IRE is a leveraged ETF targeting 2x the daily move of IREN Limited, so its drop roughly doubled IREN's -12.02% decline today.

LPTH fell -16.9% (-$2.33) to $11.46 during the regular session on Aug 28, down from a prior close of $13.79. The decline occurred intraday, not premarket or after-hours, on a volatile, high-beta optics/defense name.

AFRM is trading up +10.23% to $85.42, extending its after-hours surge from Thursday's fiscal Q4 earnings beat into today's regular session. Primary catalyst: Q4 FY2026 results topped estimates, with EPS of $4.62 versus $0.85 expected and revenue of $1.17B versus $1.11B forecast.

ESTC surged +20.97% to $101.30 from its prior close of $83.74, with the rally starting in premarket trading and extending through the regular session. The primary catalyst was a strong Q1 FY2027 earnings beat: adjusted EPS of $0.70 topped the $0.58 consensus, while revenue of $478M exceeded the ~$470M estimate.

VISN fell -41.19% to $6.84 during regular trading hours, down -$4.79 from Wednesday's close of $11.63. The move is largely mechanical: a $5.00 per-share special cash dividend went ex-dividend today, so the stock now trades without entitlement to that payout.

WHLR is trading up roughly +22.32% to ~$1.37 in early regular-session trading Friday, versus its prior close of $1.12. The rebound follows a steep -29.82% drop in the previous session, leaving the micro-cap retail REIT deeply oversold.

QNRX surged +61.95% to $7.79 during regular trading, up from a prior-session close of $4.81, extending an earlier ~45% premarket gain. Primary catalyst: positive interim Phase 2/3 data for QRX003 in Netherton Syndrome, with the primary endpoint met with statistical significance (4 of 6 patients achieved ≥1-grade IGA improvement, p=0.0087).

FNGR is up roughly +108% intraday, trading near $0.36 versus its prior close of $0.1734, extending a roughly +67% premarket surge into the regular session. Primary catalyst: new management unveiled a plan with BlueFlare Energy Solutions to build behind-the-meter AI/HPC modular data centers in Western Canada, powered by on-site natural gas and co-located bitcoin mining.

BioNTech shares are down -8.0% to $102.49, extending a drop that began in premarket trading after the company said it would end its Phase 2 colorectal cancer trial. The announcement triggered a roughly -10% premarket decline, with the stock remaining sharply lower into the regular session.

PYPL is down roughly -14.1% to about $52.80 from Thursday's $61.47 close, with the move starting in after-hours trading and extending into Friday's regular session. The primary catalyst was a late-Thursday report that the Advent International–Stripe consortium abandoned its takeover pursuit after PayPal's board rejected its $60.50-per-share ($53 billion) bid as inadequate.

NIQ shares climbed roughly 63% over the 30-day window, closing at $19.07 on August 27, 2026, compared with $11.70 on July 28, 2026. The move was powered by a second-quarter 2026 earnings beat, a raised full-year outlook, and a credit-rating upgrade from S&P Global Ratings.

Aura Minerals shares climbed roughly 61.9% over 30 days, from $55.05 to $89.12, as gold and copper prices rallied sharply. The move followed strong second-quarter results, including record net income, an increased dividend, and a new share-buyback program.

Tempus AI shares rose roughly 70% over the last 30 days, climbing from about $41.55 on July 29, 2026, to $70.69 on August 27, 2026. The sharpest move came after a Phase 3 melanoma win from Merck and Moderna validated Tempus's pending $1.5 billion acquisition of Personalis.

AngloGold Ashanti (AU) rallied roughly 52% over the trailing 30 days, climbing from about $77.87 to $118.40 as gold prices surged. The move was amplified by a strong second-quarter earnings report, a new $2 billion share buyback, and a higher dividend.

PLTU, a leveraged single-stock exchange-traded fund (ETF) seeking 200% of the daily return of Palantir Technologies ( PLTR ), advanced roughly +109% over the trailing 30 days. The surge mirrored an approximately 50% gain in PLTR and was concentrated around Palantir's second-quarter earnings release in early August, when the underlying stock jumped about 29.5% in a single session.